The coming COVID vaccine for children ages 5-11 is safe, effective and the best way for parents to protect their kids from the insidious disease, a Duke doctor who led a trial examining the vaccine’s effectiveness said Wednesday.

Dr. Emmanuel Walter Jr., a pediatrician and chief medical officer at the Duke Human Vaccine Institute, said government regulators’ expected approval of the Pfizer vaccine for use in young kids can be a true game-changer -- if enough parents choose it for their children.

“My advice to parents is this is the best way to protect your child from serious illness and potentially death from COVID, … get them vaccinated,” Walter said. “It’s the best tool we have. By all means I would recommend and suggest they get the vaccine.”

Walter led a trial at Duke examining the vaccine’s effects on youngsters, a study that evaluated several different doses. His study and others found the best results in that age group came from a 10-microgram dose, which is one-third of what adults receive. That is the dose the Food and Drug Administration is expected to soon approve for use in children 5-11.

In a virtual media briefing with reporters Wednesday, Walter discussed his study findings and the overall vaccine trial process, potential side effects, and the need for herd immunity in American communities.

Read more ➡ [ Ссылка ]

𝐓𝐡𝐞 𝐏𝐚𝐧𝐞𝐥𝐢𝐬𝐭
Dr. Emmanuel "Chip" Walter Jr. is chief medical officer of the Duke Human Vaccine Institute, where he directs the Duke Vaccine and Trials Unit. Walter is also a professor of pediatrics at Duke University School of Medicine.

𝐌𝐞𝐝𝐢𝐚 𝐁𝐫𝐢𝐞𝐟𝐢𝐧𝐠𝐬
This video is part of a series of media briefings where Duke experts speak on current issues.

Media Briefings Playlist ➡ [ Ссылка ]

𝐀𝐛𝐨𝐮𝐭 𝐃𝐮𝐤𝐞 𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲
A private research university located in Durham, North Carolina, Duke University is known as one of the world’s leading institutions for education, research, and patient care.

Subscribe ➡ [ Ссылка ]

𝐅𝐨𝐥𝐥𝐨𝐰 #𝐃𝐮𝐤𝐞𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲
Home: [ Ссылка ]
News: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
Facebook: [ Ссылка ]

свернуть